MA52961A - Compositions et procédés pour la réduction ou le traitement d'une inflammation - Google Patents

Compositions et procédés pour la réduction ou le traitement d'une inflammation

Info

Publication number
MA52961A
MA52961A MA052961A MA52961A MA52961A MA 52961 A MA52961 A MA 52961A MA 052961 A MA052961 A MA 052961A MA 52961 A MA52961 A MA 52961A MA 52961 A MA52961 A MA 52961A
Authority
MA
Morocco
Prior art keywords
inflammation
compositions
reduction
treatment
methods
Prior art date
Application number
MA052961A
Other languages
English (en)
French (fr)
Inventor
Raffi Afeyan
Simon Aoyama
Nadine Daou
Michael Hamill
Chung-Wei Lee
Harry Luithardt
Svetlana Marukian
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of MA52961A publication Critical patent/MA52961A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MA052961A 2018-06-20 2019-06-19 Compositions et procédés pour la réduction ou le traitement d'une inflammation MA52961A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862687724P 2018-06-20 2018-06-20
US201862758249P 2018-11-09 2018-11-09
US201962794165P 2019-01-18 2019-01-18

Publications (1)

Publication Number Publication Date
MA52961A true MA52961A (fr) 2021-04-28

Family

ID=67253998

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052961A MA52961A (fr) 2018-06-20 2019-06-19 Compositions et procédés pour la réduction ou le traitement d'une inflammation

Country Status (6)

Country Link
US (1) US20210260010A1 (https=)
EP (1) EP3810276A1 (https=)
JP (1) JP2021529736A (https=)
CN (1) CN112839712A (https=)
MA (1) MA52961A (https=)
WO (1) WO2019246310A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JP2021529735A (ja) 2018-06-20 2021-11-04 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． アミノ酸組成物の製造方法
US20210379118A1 (en) * 2018-10-19 2021-12-09 Regenics As Use of egg cellular extract for wound healing
WO2023009444A1 (en) * 2021-07-26 2023-02-02 Axcella Health Inc. Amino acid compositions and methods for use in the treatment of post-acute sequelae of covid-19
US11622949B1 (en) 2022-08-04 2023-04-11 Gad M. Gilad Agmatine compositions for treatment of osteoarthritis
US12285541B2 (en) 2023-01-26 2025-04-29 Insignia Pharmaceuticals, Llc Pharmaceutical compositions for treating osteoarthritis
CN116549428B (zh) * 2023-06-20 2025-05-16 郑州大学 4-羟基异亮氨酸的新用途
WO2025155743A1 (en) * 2024-01-16 2025-07-24 The Johns Hopkins University Chemokine ligand 18 (ccl18) for diagnosis and treatment of inflammatory lung disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2007004613A1 (ja) * 2005-07-01 2009-01-29 味の素株式会社 炎症性腸疾患治療薬及びＴＮＦ−α産生抑制剤
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
CN100518815C (zh) * 2007-02-15 2009-07-29 北京苏里曼医药科技有限公司 一种氨基酸组合物
CA2863809A1 (en) * 2012-02-06 2013-08-15 Ajinomoto Co., Inc. Prophylactic or therapeutic agent for idiopathic inflammatory myopathies
KR102324674B1 (ko) * 2015-11-02 2021-11-11 (주)모아캠 아미노산 및 해양 심층수 추출 미네랄을 유효성분으로 함유하는 화장료 조성물
JOP20190147A1 (ar) * 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات

Also Published As

Publication number Publication date
US20210260010A1 (en) 2021-08-26
EP3810276A1 (en) 2021-04-28
WO2019246310A1 (en) 2019-12-26
JP2021529736A (ja) 2021-11-04
CN112839712A (zh) 2021-05-25

Similar Documents

Publication Publication Date Title
MA52961A (fr) Compositions et procédés pour la réduction ou le traitement d'une inflammation
EP3612215A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF Pneumonia
EP3947715A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP3894392A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
EP3630072A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF EXCESSIVE Drowsiness
MA54609A (fr) Inhibiteurs aza-hétérobicycliques de mat2a et procédés d'utilisation pour le traitement du cancer
MA54608A (fr) Inhibiteurs aza-hétérobicycliques de mat2a et procédés d'utilisation pour le traitement du cancer
MA56050A (fr) Inhibiteurs hétérobicycliques de mat2a et procédés d'utilisation pour le traitement du cancer
MA53873A (fr) Compositions et procédés pour le traitement de la presbytie
MA50849A (fr) Substances et procédés pour le traitement d'hémoglobinopathies
MA51796A (fr) Procédés et compositions pour l'administration de protéines thérapeutiques
EP3615016A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF SLEEP APNEA
MA71705A (fr) Substances et procédés pour le traitement d'hémoglobinopathies
EP3908601A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP3448421A4 (en) METHOD AND COMPOSITIONS FOR PREVENTING AND TREATING SURGICAL ADHESIVES
EP3781143A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF IRON OVERLOAD
MA52971A (fr) Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
EP3876967A4 (en) Therapeutic microbiota for the treatment and/or prevention of dysbiosis
EP4297871A4 (en) METHODS AND COMPOSITIONS FOR TREATING AGITATION
EP3810091A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF PULMONARY HYPERTENSION
EP3801478A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF CALCIPHYLAXIA
MA55490A (fr) Mutéine de lipocaline pour le traitement de l'asthme
EP4045046A4 (en) Methods and compositions for treating iron disorders
EP3500282A4 (en) ANTI-INFLAMMATION COMPOSITION FOR THE TREATMENT OF ACUTE ARTICALLY INFLAMMATION AND METHOD FOR THE PRODUCTION THEREOF
EP3801587A4 (en) ACYLATED CATECHIN POLYPHENOLS AND METHODS OF USE THEREFORE FOR THE TREATMENT OF CANCER